Dual-luciferase assay indicated the increased and decreased HNF4A-AS1 promoter activity in NB cells transfected with MYCN or sh-MYCN, which was abolished by mutation of MYCN-binding site (Additional file 1: Figure S4d). The gene discussed is PTGDR; the disease is neuroblastoma.